Slidex Rota-Kit 2 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Biomerieux S/A Brasil 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    829
  • 날짜
    2006-04-24
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    The product is registered in Brazil under the nº 10158120201, valid until 19-12-2006. There are currently no notifications of technical complaints about the product involved in this Alert 829. The Technovigilance Unit is monitoring the actions taken by the company and warns of the importance of customers being aware of the problem and of notifying any technical complaints (technical surveillance @ anvisa.gov.br). The Technovigilance Unit was notified by the company on April 24, 2006. Biomérieux Brasil SA addressed a letter to the clients on 04-07-2006. UPDATE: 06-13-2006: 1.Company sent a letter to the UTVIG (received at Anvisa on 06-07-2006) informing that it has already collected all kits involved in the Alert. 2.The company was directed to seek the State Sanitary Surveillance Center / RJ to carry out the destruction according to the guidelines of the said Center. I look forward to returning information to update the Alert and terminate the notification. UPDATE: 01/22/2007: Company reported that the products were incinerated and that VISA RJ was informed of this procedure on 12/26/2006 by means of correspondence registered in said VISA on 12/27/2006. This notification is now closed.
  • 원인
    Biomérieux brasil sa communicated the decision of biomérieux brasil s / a to collect the lots 50608 (validity: august 10, 2006) through the national agency of sanitary surveillance (anvisa), through its utvig, and 50609 (validity: august 10, 2006) of the product slidex rota-kit 2. these batches have been shown to have, over time, a gradual loss of sensitivity of the latex r1 reagent, causing low agglutination of the r3 positive control, leading to possibility of false-positive results. this result does not cause an adverse event in the patient, however it does not allow the correct identification of the gastrointestinal agent and may lead to abusive prescription of antibiotics not indicated for the treatment of gastroenteritis of viral etiology. the company received a complaint from brazil, in addition to 13 other countries.
  • 조치
    The Company Biomérieux Brasil SA informed its clients and started the voluntary withdrawal of the market of the unused lots involved in the problem and blocked the commercialization of these lots that are still in stock.

Device

Manufacturer

  • Source
    ANVSANVISA